Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bodhi Tree Biotechnology (BDTB) EBIT Margin (2024 - 2025)

Bodhi Tree Biotechnology (BDTB) has disclosed EBIT Margin for 2 consecutive years, with 89.06% as the latest value for Q3 2025.

  • Quarterly EBIT Margin changed N/A to 89.06% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1131.58% through Dec 2025, changed N/A year-over-year, with the annual reading at 868.34% for FY2025, N/A changed from the prior year.
  • EBIT Margin for Q3 2025 was 89.06% at Bodhi Tree Biotechnology, up from 1295.54% in the prior quarter.
  • The five-year high for EBIT Margin was 89.06% in Q3 2025, with the low at 1295.54% in Q4 2024.